Tuberculin Skin Test and Anergy in Dialysis Patients of a Tuberculosis-Endemic Area

Background/Aim: Uremic patients are at an increased risk of being affected by tuberculosis (TB). Periodical tuberculin skin tests were suggested to detect TB-infected patients. These were replaced by chest radiographs in endemic areas like Taiwan. However, almost 50% of the TB incidence in dialysis patients was extrapulmonary. In this study, we tried to investigate the value of tuberculin tests in dialysis patients in endemic areas. Methods: The patients were recruited from our dialysis unit. Purified protein derivative (PPD) and control tests with antigens for Candida and toxoid were performed using the Mantoux method. PPD with >10-mm induration will be considered positive. Skin anergy meant that the indurations of all antigens were less than 5 mm. A follow-up was done 12 months after the tests. Results: A total of 177 patients were evaluated. Anergy was found in 40 patients (22.6%). A positive predictor of anergy was age >45 years (p = 0.03), while a negative predictor was prealbumin >20 mg/dl (p = 0.04). Fifty-three patients (30%) had positive PPD tests. Seven of the positive PPD patients (13.2%) developed active TB during the following years. Among the 40 patients with skin anergy, 6 (15%) were found to have active TB. Of the 48 patients (21.1%) with indurations of the PPD tests between 5 and 10 mm, none was found to have active TB. Conclusion: Although anergy will influence the sensitivity of PPD tests, these tests in combination with anergy tests could help to establish the diagnosis of TB in uremic patients, even in TB-endemic areas.

[1]  J. Im,et al.  Tuberculosis in patients with end-stage renal disease. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  K. Chou,et al.  Tuberculosis in Maintenance Dialysis Patients , 2001, Nephron.

[3]  V. Fraser,et al.  Tuberculosis infection and anergy in hemodialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  B. Seckler,et al.  Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. , 1998, Chest.

[5]  W. Hörl,et al.  Immune dysfunction in uremia. , 1997, Kidney international. Supplement.

[6]  B. Pereira,et al.  A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients. , 1997, Seminars in nephrology.

[7]  R. Chaisson,et al.  Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients , 1996 .

[8]  A. Mitwalli Tuberculosis in patients on maintenance dialysis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  S. Rostand,et al.  Mycobacteriosis in patients with chronic renal failure. , 1980, Archives of internal medicine.

[10]  A. Ruffino-Netto [Tuberculin test]. , 1979, AMB : revista da Associacao Medica Brasileira.

[11]  E. Friedman,et al.  Tuberculosis in patients undergoing maintenance hemodialysis. , 1979, The American journal of medicine.

[12]  S. Sasaki,et al.  Ten years' survey of dialysis-associated tuberculosis. , 1979, Nephron.

[13]  J. Revillard,et al.  T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. , 1975, Nephron.

[14]  W. P. Reed,et al.  Delayed hypersensitivity skin testing. II. Clinical correlates and anergy. , 1974, The Journal of infectious diseases.

[15]  J. Sanford,et al.  Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. , 1971, The Journal of clinical investigation.

[16]  H. Waaler,et al.  Standardization of a new batch of purified tuberculin (PPD) intended for international use. , 1958, Bulletin of the World Health Organization.